Streetbeat News

Partnerships

BYDDF

BYDDY

Warren Buffett-backed Chinese EV giant BYD is opening its first Southeast Asia factory in Thailand, coinciding with new EU tariffs on Chinese EVs. The $486 million facility aims to export most of its 150,000 annual capacity to Southeast Asia and Europe. Despite challenges, including reduced profit forecasts and Berkshire Hathaway reducing its stake, BYD continues its aggressive international growth strategy.

Portfolio Pulse from Benzinga Neuro

July 03, 2024 | 8:24 am

JNPR

The Milano Cortina 2026 Foundation has signed a partnership agreement with Juniper Networks for the Milano Cortina 2026 Olympic and Paralympic Winter Games.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 7:02 am

MGNI

Magnite (NASDAQ:MGNI) announced that CairoRCS Media, a major Italian communication group, is implementing Magnite's Demand Manager to enhance programmatic monetization of their display and video inventory. The solution, built on Prebid technology, offers tools and insights to help publishers grow revenue.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 7:00 am

CVAC

GSK

GSK and CureVac have restructured their collaboration into a new licensing agreement, with GSK taking full control of developing and manufacturing mRNA vaccines. CureVac will receive €400M upfront and up to €1.05B in milestones. The agreement allows both companies to focus on their respective mRNA development activities.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 6:57 am

CVAC

CureVac N.V. (NASDAQ:CVAC) is restructuring to focus on high-value mRNA projects, reducing its workforce by 30%. The restructuring follows a new licensing agreement with GSK, valued at up to €1.45 billion plus royalties. CureVac aims to streamline operations, prioritize oncology programs, and reduce operational expenses by over 30% from 2025 onward.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 6:56 am

CVAC

GSK

GSK and CureVac have restructured their partnership to focus on mRNA vaccine development. GSK will take full control of developing and manufacturing the candidate vaccines, while CureVac will receive significant financial compensation and retain rights to other targets.

Portfolio Pulse from Benzinga Newsdesk

July 03, 2024 | 6:53 am

MSFT

NVDA

Microsoft's $1 billion AI project with UAE's G42 in Kenya is under scrutiny due to national security concerns. The deal involves Microsoft investing $1.5 billion in G42, contingent on G42 severing ties with Chinese companies. However, Pentagon officials are skeptical about G42's complete disengagement from China. The scrutiny could impact the shipment of Nvidia's H100 chips to the Middle East and affect U.S. efforts to lead in AI development.

Portfolio Pulse from Ananya Gairola

July 03, 2024 | 3:48 am

AAPL

MSFT

Apple's former marketing chief, Phil Schiller, will join OpenAI's board as an observer, giving Apple equal status with Microsoft. This move follows Apple's decision to integrate ChatGPT into its devices and highlights the growing partnership between Apple and OpenAI.

Portfolio Pulse from Ananya Gairola

July 03, 2024 | 1:58 am

BHR

Braemar Hotels & Resorts will add an independent director to its Board with input from Blackwells, which will become a significant shareholder by purchasing 3.5 million shares of Braemar's stock.

Portfolio Pulse from Benzinga Newsdesk

July 02, 2024 | 10:04 pm

RIVN

Rivian Automotive Inc (NASDAQ:RIVN) shares are trading lower in after-hours following reports that the company has no plans to produce vehicles with Volkswagen under their recently announced joint venture. Despite earlier reports suggesting potential hardware and joint production, Rivian confirmed it will continue its R2 production independently.

Portfolio Pulse from Adam Eckert

July 02, 2024 | 8:58 pm